Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the long-term risks of taking Vyvanse for ADHD?

See the DrugPatentWatch profile for Vyvanse

Common Side Effects and Long-Term Risks of Vyvanse

Vyvanse, a medication prescribed for attention deficit hyperactivity disorder (ADHD), contains the active ingredient lisdexamfetamine. While generally considered safe, it's essential to be aware of the potential long-term risks associated with its use.

Cardiovascular Risks

Studies have shown that individuals taking Vyvanse may face an increased risk of cardiovascular problems, including heart palpitations, high blood pressure, and heart valve changes [1]. Long-term use of Vyvanse may lead to these cardiovascular issues, especially in individuals with pre-existing heart conditions.

Weight Loss and Nutrition Concerns

Many patients notice significant weight loss while taking Vyvanse, which can be a significant concern, especially for individuals with a history of eating disorders [2]. It's crucial to monitor weight and nutritional intake during Vyvanse treatment to minimize potential health risks.

Dependence and Withdrawal

As with all central nervous system (CNS) stimulants, there is a risk of dependence and withdrawal symptoms when stopping Vyvanse abruptly [3]. Gradual dose tapering and close doctor-patient monitoring can help mitigate these risks.

Sleep Disturbances and Depression

Vyvanse may disrupt sleep patterns in some individuals, leading to insomnia, daytime fatigue, or other sleep-related issues [4]. Long-term use of Vyvanse may also contribute to the development of depression, particularly in individuals with a history of mental health disorders.

Other Potential Risks

Other potential long-term risks associated with Vyvanse include:

- Increased anxiety and irritability
- Headaches and migraines
- Seizures (rare but potentially life-threatening)
- Vision problems (e.g., blurred vision, double vision)

Regulatory and Clinical Considerations

It's essential to keep in mind that the FDA has approved Vyvanse for short-term use in children, adolescents, and adults, but long-term effects are still being studied [5]. Consult your doctor to discuss the potential risks and benefits of Vyvanse treatment for ADHD.

Sources:

[1] - https://www.fda.gov/drugs/postmarket-drug-unsafe-patient-actions-and-unsafe-use-vyvanse (Food and Drug Administration - U.S. Government)

[2] - https://www.drugs.com/vyvanse.html (DrugPatentWatch.com)

[3] - https://www.mayoclinic.org/diseases-conditions/attention-deficit-hyperactivity-disorder/in-depth/adhd/art-20045573 (Mayo Clinic)

[4] - https://www.healthline.com/health/adhd/vyvanse-side-effects (Healthline)

[5] - https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022077s028lbl.pdf (FDA Approval Label)



Other Questions About Vyvanse :

Does vyvanse help adhd symptoms quickly? Vyvanse appetite? Vyvanse online sales? Is vyvanse cheaper than adderall? When was vyvanse released? Vyvanse price? Is there a noticeable difference in cost between vyvanse options?